amifostine anhydrous has been researched along with Bladder Cancer in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a series of patients with bladder cancer treated with hypofractionated accelerated radiotherapy with amifostine cytoprotection, with or without concurrent liposomal doxorubicin." | 1.34 | Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer. ( Koukourakis, MI; Touloupidis, S; Tsolos, C, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koukourakis, MI | 1 |
| Tsolos, C | 1 |
| Touloupidis, S | 1 |
| Heidenreich, A | 1 |
| Marx, FJ | 1 |
| Peters, HJ | 1 |
1 trial available for amifostine anhydrous and Bladder Cancer
| Article | Year |
|---|---|
[Amifostine as protective agent in cisplatin-based chemotherapy of advanced bladder cancer].
Topics: Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chem | 1999 |
1 other study available for amifostine anhydrous and Bladder Cancer
| Article | Year |
|---|---|
Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
Topics: Aged; Aged, 80 and over; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; | 2007 |